These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3199591)

  • 1. (R)-3-[(S)-1-carboxy-5-(4-piperidyl)pentyl]amino-4-oxo-2,3,4,5- tetrahydro-1,5-benzothiazepine-5-acetic acid (CV-5975): a new potent and long-lasting inhibitor of angiotensin converting enzyme.
    Inada Y; Itoh K; Kamiya K; Sugihara H; Nishikawa K
    Jpn J Pharmacol; 1988 Jun; 47(2):135-41. PubMed ID: 3199591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive action of a new angiotensin converting enzyme inhibitor, (R)-3-[(S)-1-carboxy-5-(4-piperidyl)pentyl]amino-4-oxo-2,3,4,5-tetr ahy dro-1,5-benzothiazepine-5-acetic acid (CV-5975), in various hypertensive models.
    Inada Y; Tanabe M; Kawazoe K; Nishikawa K
    Jpn J Pharmacol; 1988 Jul; 47(3):311-22. PubMed ID: 2851677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of angiotensin converting enzyme by (R)-3-[(S)-1-carboxy-5-(4-piperidyl)pentyl]amino-4-oxo-2,3,4,5-tetra- hydro-1,5-benzothiazepine-6-acetic acid (CV-5975), a non-sulfhydryl compound.
    Inada Y; Tanabe M; Itoh K; Sugihara H; Nishikawa K
    Jpn J Pharmacol; 1988 Nov; 48(3):323-30. PubMed ID: 2851678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors: perhydro-1,4-thiazepin-5-one derivatives.
    Yanagisawa H; Ishihara S; Ando A; Kanazaki T; Miyamoto S; Koike H; Iijima Y; Oizumi K; Matsushita Y; Hata T
    J Med Chem; 1987 Nov; 30(11):1984-91. PubMed ID: 3669006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and angiotensin converting enzyme-inhibitory activity of N-[(1S)-1-carboxy-5-(4-piperidyl)pentyl]-L-alanine derivatives.
    Kori M; Itoh K; Inada Y; Katoh T; Sumino Y; Nishikawa K; Sugihara H
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):580-5. PubMed ID: 8004703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid reversal of angiotensin I-induced contractions in rat carotid arteries after acute and chronic treatment with the angiotensin-converting enzyme inhibitor, 3-[(5-amino-1-carboxy-1S-pentyl)amino]2,3,4,5-tetrahydro-2-oxo- 3S-1H-1-benzazepena-1-acetic acid (CGS 16617).
    Weiss GB; Sturm B; Levens NR
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1407-13. PubMed ID: 8263802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and angiotensin converting enzyme inhibitory activity of N-carboxymethyldipeptides with omega-(4-piperidyl)alkyl group.
    Waga T; Matsui S; Saito S; Watanabe M; Kajiwara Y; Shirota M; Iijima M; Kitabatake K
    Arzneimittelforschung; 1990 Apr; 40(4):407-13. PubMed ID: 2162675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: rational design, bioavailability, and pharmacological responses in experimental hypertension.
    Fournié-Zaluski MC; Coric P; Turcaud S; Rousselet N; Gonzalez W; Barbe B; Pham I; Jullian N; Michel JB; Roques BP
    J Med Chem; 1994 Apr; 37(8):1070-83. PubMed ID: 8164250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivatives.
    Slade J; Stanton JL; Ben-David D; Mazzenga GC
    J Med Chem; 1985 Oct; 28(10):1517-21. PubMed ID: 2995670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and angiotensin converting enzyme inhibitory activity of 1,5-benzothiazepine and 1,5-benzoxazepine derivatives. I.
    Itoh K; Kori M; Inada Y; Nishikawa K; Kawamatsu Y; Sugihara H
    Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1128-47. PubMed ID: 3015433
    [No Abstract]   [Full Text] [Related]  

  • 11. 1,2-Cyclomethylenecarboxylic monoamide hydroxamic derivatives. A novel class of non-amino acid angiotensin converting enzyme inhibitors.
    Turbanti L; Cerbai G; Di Bugno C; Giorgi R; Garzelli G; Criscuoli M; Renzetti AR; Subissi A; Bramanti G; DePriest SA
    J Med Chem; 1993 Mar; 36(6):699-707. PubMed ID: 8459398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors. 2. Perhydroazepin-2-one derivatives.
    Yanagisawa H; Ishihara S; Ando A; Kanazaki T; Miyamoto S; Koike H; Iijima Y; Oizumi K; Matsushita Y; Hata T
    J Med Chem; 1988 Feb; 31(2):422-8. PubMed ID: 3339612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on angiotensin converting enzyme inhibitors. 4. Synthesis and angiotensin converting enzyme inhibitory activities of 3-acyl-1-alkyl-2-oxoimidazolidine-4-carboxylic acid derivatives.
    Hayashi K; Nunami K; Kato J; Yoneda N; Kubo M; Ochiai T; Ishida R
    J Med Chem; 1989 Feb; 32(2):289-97. PubMed ID: 2913292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profiles of CS-622, a novel angiotensin converting enzyme inhibitor.
    Oizumi K; Koike H; Sada T; Miyamoto M; Nishino H; Matsushita Y; Iijima Y; Yanagisawa H
    Jpn J Pharmacol; 1988 Nov; 48(3):349-56. PubMed ID: 2851680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR).
    Ishizuka H; Konno K; Naganuma H; Sasahara K; Kawahara Y; Niinuma K; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1304-11. PubMed ID: 9067317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors: new orally active 1,4-thiazepine-2,5-diones, 1,4-thiazine-2,5-diones, and 1,4-benzothiazepine-2,5-diones possessing antihypertensive activity.
    Skiles JW; Suh JT; Williams BE; Menard PR; Barton JN; Loev B; Jones H; Neiss ES; Schwab A; Mann WS
    J Med Chem; 1986 May; 29(5):784-96. PubMed ID: 3009814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitors: structure-activity profile of 1-benzazepin-2-one derivatives.
    Stanton JL; Watthey JW; Desai MN; Finn BM; Babiarz JE; Tomaselli HC
    J Med Chem; 1985 Nov; 28(11):1603-6. PubMed ID: 2999394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of potent new angiotensin converting enzyme inhibitors containing saturated bicyclic amino acids.
    Blankley CJ; Kaltenbronn JS; DeJohn DE; Werner A; Bennett LR; Bobowski G; Krolls U; Johnson DR; Pearlman WM; Hoefle ML
    J Med Chem; 1987 Jun; 30(6):992-8. PubMed ID: 3035180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 2-substituted-N-carboxymethyl-1,5-benzothiazepin-4-ones and -1,4-benzothiazin-3-ones and their evaluation as angiotensin converting enzyme inhibitors.
    Trapani G; Latrofa A; Franco M; Liso G
    Farmaco; 1995 Feb; 50(2):107-12. PubMed ID: 7766274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and angiotensin converting enzyme-inhibitory activity of 1,5-benzothiazepine and 1,5-benzoxazepine derivatives. III.
    Itoh K; Kori M; Inada Y; Nishikawa K; Kawamatsu Y; Sugihara H
    Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3747-61. PubMed ID: 3028653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.